Список литературы

1. Александров А.А., Кисляк О.А., Леонтьева И.В., Розанов В.Б. Диагностика, лечение и профилактика артериальной гипертензии у детей и подростков. Российские рекомендации (второй пересмотр). Кардиоваскулярная терапия и профилактика 2009; 8: (4; приложение 1) 1 - 32. 4: 1 - 32.

2. Александров А.А.., Кисляк О.А., Леонтьева И.В. и др./Клинические рекомендации Системные гипертензии. 2020; 17:2: 7 - 35.

3. Чазова И.Е., Жернакова Ю.Е. Клинические рекомендации Диагностика, лечение артериальной гипертензии. Системные гипертензии 2019; 16: 6 - 31.

4. Williams B., Mancia G., Spiering W., Agabiti Rosei E., Azizi M., Burnier M. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018; 00: 1 - 98.

5. Rosenberg WM, Gray JA et al. Evidence based medicine: what it is and what it isn't. BMJ 1996, January; 312 (7023): 71 - 72.

6. Андреева Н.С., Реброва О.Ю., Зорин Н.А. и др. Системы оценки достоверности научных доказательств и убедительности рекомендаций: сравнительная характеристика и перспективы унификации. Медицинские технологии. Оценка и выбор. 2012. N. 4: 10 - 24.

7. Lurbe E., Agabiti-Roseic E., Cruickshankd J.K, Dominiczake A., Erdinef S., Hirthg A., et.al. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens. 2016. Oct; 34(10): 1887-920. doi: 10.1097/HJH.0000000000001039

8. Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, de Ferranti SD, Dionne JM, Falkner B, Flinn SK, Gidding SS, Goodwin C, Leu MG, Powers ME, Rea C, Samuels J, Simasek M, Thaker VV, Urbina EM. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics. 2017; 140(3): e20171904.

9. Леонтьева И.В., Александров А.А., Розанов В.Б. Артериальная гипертензия у детей и подростков. Москва, 2010. 246 с.

10. Bochud M, Bovet P, Elston RC, Paccaud F, Falconnet C, Maillard M, et al. High heritability of ambulatory blood pressure in families of East African descent. Hypertension 2005; 45: 445 - 450.

11. Rosner B, Cook NR, Daniels S, Falkner B. Childhood blood pressure trends and risk factors for high blood pressure: the NHANES experience 1988 - 2008. Hypertension. 2013; 62(2): 247-54.

12. Kelishadi R, Mirmoghtadaee P, Najafi H, Keikha M. Systematic review on the association of abdominal obesity in children and adolescents with risk factors. J Res Med Sci. 2015; 20(3): 294 - 307

13. Friedemann C, Heneghan C, Mahtani K, Thompson M, Perera R, Ward AM. Cardiovascular disease risk in healthy children and its association with body mass index: systematic review and meta-analysis. BMJ. 2012; 345: e4759

14. Flechtner-Mors M, Neuhauser H, Reinehr T, Roost HP, Wiegand S, Siegfried W. et al. APV initiative and the BMBF Competence Network Obesity. Blood pressure in 57,915 pediatric patients who are overweight or obese based on five reference systems. Am J Cardiol 2015; 115: 1587 - 1594.

15. Parker ED, Sinaiko AR, Kharbanda EO, et al. Change in weight status and development of hypertension. Pediatrics. 2016; 137(3): e20151662

16. Koebnick C, Black MH, Wu J, et al. High blood pressure in overweight and obese youth: implications for screening. J Clin Hypertens (Greenwich). 2013; 15(11): 793 - 805.

17. Zhang T, Zhang H, Li S, et al. Impact of adiposity on incident hypertension is modified by insulin resistance in adults: longitudinal observation from the Bogalusa Heart Study. Hypertension. 2016; 67(1): 56 - 62.

18. Kaelber DC. IBM explorys cohort discovery tool. Available at: www. ibm. com/watson/health/explorys. Accessed February 3, 2017

19. Halbach SM, Martz K, Mattoo T, Flynn J. Predictors of blood pressure and its control in pediatric patients receiving dialysis. J Pediatr. 2012; 160(4): 621 - 625.

20. Hartzell K, Avis K, Lozano D, Feig D. Obstructive sleep apnea and periodic limb movement disorder in a population of children with hypertension and/or nocturnal nondipping blood pressures. J Am Soc Hypertens. 2016; 10(2): 101 - 107.

21. Archbold KH, Vasquez MM, Goodwin JL, Quan SF. Effects of sleep patterns and obesity on increases in blood pressure in a 5-year period: report from the Tucson Children's Assessment of Sleep Apnea Study. J Pediatr. 2012; 161(1): 26 - 30.

22. Au CT, Ho CK, Wing YK, Lam HS, Li AM. Acute and chronic effects of sleep duration on blood pressure. Pediatrics. 2014; 133(1). Available at: www. pediatrics. org/cgi/content/full/133/1/e64

23. Александров А.А., Бубнова М.Г., Кисляк О.А. и др. Профилактика сердечно-сосудистых заболеваний в детском и подростковом возрасте. Российские рекомендации. Российский кардиологический журнал 2012; N 6 (Прил. 1): С. 1 - 40.

24. Dionne J. et al. Pediatric Nephrology Hypertension in infancy: diagnosis, management and outcome//January 2012, Volume 27, Issue 1: 17 - 32.

25. Hager A, Kanz S, Kaemmerer H, Schreiber C, Hess J. Coarctation Long-term Assessment (COALA):significance of arterial hypertension in a cohort of 404 patients up to 27 years after surgical repair of isolated coarctation of the aorta, even in the absence of restenosis and prosthetic material. J Thorac Cardiovasc Surg. 2007; 134(3): 738 - 745.

26. Di Salvo G, Castaldi B, Baldini L, Gala S, del Gaizo F, D'Andrea A, et al.Masked hypertension in young patients after successful aortic coarctation repair: impact on left ventricular geometry and function. J Hum Hypertens 2011; 25: 739 - 745.

27. Mattoo K. Evaluation and diagnosis of hypertension in infants between one month and one year of age//UpToDate This topic last updated: Jun 11, 2020.

28. O'Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, et al., European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 2013; 31: 1731 - 1768.

29. , Witte K, Soergel M, Mehls O, Schaefer F, German Working Group on Pediatric Hypertension. Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 2002; 20: 1995 - 2007.

30. , Zigman T, , Malenica M, Cuk M. The importance of ambulatory blood pressure monitoring in children and adolescents. Acta Clin Croat. 2012; 51(1): 59 - 64.

31. Swartz SJ, Srivaths PR, Croix B, Feig DI. Cost-effectiveness of ambulatory blood pressure monitoring in the initial evaluation of hypertension in children. Pediatrics. 2008; 122(6): 1177 - 1181

32. Kavey RE, Kveselis DA, Atallah N, Smith FC. White coat hypertension in childhood: evidence for end-organ effect. J Pediatr. 2007; 150(5): 491 - 497.

33. Mitsnefes M, Flynn J, Cohn S, et al; CKiD Study Group. Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol. 2010; 21(1): 137 - 144

34. Lurbe E, Thijs L, Torro MI, Alvarez J, Staessen JA, Redon J. Sexual dimorphism in the transition from masked to sustained hypertension in healthy youths. Hypertension 2013; 62: 410 - 414.

35. Аверьянов С.Н., Амчеславский В.Г., Багаев В.Г., Тепаев Р.Ф. Определение скорости клубочковой фильтрации у детей: история и современные подходы. Педиатрическая фармакология. 2018; 15 (3): 218 - 223.doi: 10.15690/pf.v15i3.1901

36. Giraldi PF, Ambrogio AG, De Martin M, et al. Specificity of first-line tests for the diagnosis of Cushing's syndrome: assessment in a large series. J Clin Endocrinol Metab. 2007; 92(11): 4123-9. doi: 10.1210/jc.2007 - 0596

37. Korbonits M, Blair JC, Boguslawska A et al. Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 2, specific diseases//Nature Reviews Endocrinology; 2024; 20 (5); 290 - 309

38. Mancia G., Fagard R., Narkiewicz K., Redon J., Zanchetti A., Bohm M. et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34: 2159 - 2219. DOI: 10.1093/eurheartj/eht151

39. Khoury PR, Mitsnefes M, Daniels SR, Kimball TR. Age-specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr 2009; 22: 709 - 714.

40. Moller N C, Grontvve A., Wedderkopp N. Cardiovascular disease risk factors and blood pressure response during in exercise during in health children and adolescents the European Youth Heart study J Appl Physiol 2010; 109: 1125 - 1132.

41. Foster BJ, Khoury PR, Kimball TR, Mackie AS, Mitsnefes M. New reference centiles for left ventricular mass relative to lean body mass in children. J Am Soc Echocardiogr. 2016; 29(5): 441 - 447.e2

42. Chinali M, Emma F, Esposito C, Rinelli G, Franceschini A, Doyon A, et al. Left ventricular mass indexing in infants, children, and adolescents: a simplified approach for the identification of left ventricular hypertrophy in clinical practice. J Pediatr 2016; 170: 193 - 198.

43. Lopez L, Colan SD, Frommelt PC, et al. Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council. J Am Soc Echocardiogr. 2010; 23(5): 465 - 495, quiz 576 - 577.

44. Daniels SR, Kimball TR, Morrison JA, Khoury P, Witt S, Meyer RA. Effect of lean body mass, fat mass, blood pressure, and sexual maturation on left ventricular mass in children and adolescents. Statistical, biological, and clinical significance. Circulation. 1995; 92(11): 3249 - 3254.

45. Lubrano R, Travasso E, Raggi C, Guido G, Masciangelo R, Elli M. Blood pressure load, proteinuria and renal function in prehypertensive children. Pediatr Nephrol 2009; 24: 823 - 831.

46. Agarwal A, Kapur G, Altinok D. Childhood posterior reversible encephalopathy syndrome: magnetic resonance imaging findings with emphasis on increased leptomeningeal FLAIR signal. Neuroradiol J 2015; 28: 638 - 643.

47. Hager A, Kanz S, Kaemmerer H, Schreiber C, Hess J. Coarctation Long-term Assessment (COALA): significance of arterial hypertension in a cohort of 404 patients up to 27 years after surgical repair of isolated coarctation of the aorta, even in the absence of restenosis and prosthetic material. J Thorac Cardiovasc Surg. 2007; 134(3): 738 - 745.

48. Di Salvo G, Castaldi B, Baldini L, Gala S, del Gaizo F, D'Andrea A, et al.Masked hypertension in young patients after successful aortic coarctation repair: impact on left ventricular geometry and function. J Hum Hypertens 2011; 25: 739 - 745.

49. Giordano U, Cifra B, Giannico S, Turchetta A, Calzolari A. Mid-term results, and therapeutic management, for patients suffering hypertension after surgical repair of aortic coarctation. Cardiol Young 2009; 19: 451 - 455.

50. Elkins C, Fruh S, Jones L, Bydalek K. Clinical Practice Recommendations for Pediatric Dyslipidemia The Pediatr Health Care. Jul-Aug 2019; 33(4): 494 - 504. doi: 10.1016/j.pedhc.2019.02.009

51. Zimmet P, Alberti KG, Kaufman F, Tajima N. et a. IDF Consensus Group. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes. 2007 Oct; 8(5): 299 - 306.

52. Dionne J.M., Harris K.C., Benoit G., FeberJ., Poirier L., Cloutier L. et al. Hypertension Canada's 2017 Guidelines for the Diagnosis, Assessment, Prevention, and Treatment of Pediatric Hypertension. CJC 2017; 33(5): 557 - 688. DOI.org/10.1016/j.cjca.2017.03.007

53. Moore L.L., Bradlee M.L., Singer M.R., Qureshi M.M., Buendia J.R., Daniels S.R. Dietary approaches to stop hypertension (DASH) eating pattern and risk of elevated blood pressure in adolescent girls. Br J Nutr 2012; 108(9): 1678 - 1685. DOI: 10.1017/S000711451100715X

54. Torrance B., McGuire K.A., Lewanczuk R., McGavock J. Overweight, physical activity and high blood pressure in children: a review of the literature. Vasc Health Risk Manag 2007; 3(1): 139 - 149.

55. Farpour-Lambert N.J., Aggoun Y., Marchand L.M., Martin X.E., Herrmann F.R., Beghetti M. Physical activity reduces systemic blood pressure and improves early markers of atherosclerosis in pre-pubertal obese children. J Am Coll Cardiol 2009; 54(25): 2396 - 2406. DOI: 10.1016/j.jacc.2009.08.030

56. Kelley G.A., Kelley K.S., Tran Z.V. The effects of exercise on resting blood pressure in children and adolescents: a meta-analysis of randomized controlled trials. Prev Cardiol 2003; 6(1): 8 - 16.

57. Tompkins C.L., Moran K., Preedom S., Brock D.W. Physical activity-induced improvements in markers of insulin resistance in overweight and obese children and adolescents. Curr Diabetes Rev 2011; 7(3): 164 - 170.

58. Luehrs RE, Zhang D, Pierce GL, Jacobs DR Jr, Kalhan R, Whitaker KM. Cigarette Smoking and Longitudinal Associations With Blood Pressure: The CARDIA Study. J Am Heart Assoc. 2021 May 4; 10(9):e019566. doi: 10.1161/JAHA.120.019566.

59. Damasceno M.M., , deFreitas R.W., de Almeida P.C., Zanetti M.L. The association between blood pressure in adolescents and the consumption of fruits, vegetables and fruit juice--an exploratory study. J Clin Nurs 2011; 20(11-12): 1553 - 1560.

60. Saneei P., Hashemipour M., Kelishadi R., Rajaei S., Esmaillzadeh A. Effects of recommendations to follow the dietary approaches to stop hypertension (DASH) diet v. usual dietary advice on childhood metabolic syndrome: a randomized cross-over clinical trial. Br J Nutr 2013; 110(12): 2250 - 2259. DOI: 10.1017/S0007114513001724

61. Yang Q., Zhang Z, Kuklina E.V. et al. Sodium intake and blood pressureamong US children and adolescents. Pediatrics 2012; 130(4): 611 - 619. DOI: 10.1542/peds. 2011 - 3870

62. Resnicow K., McMaster F., Bocian A., et al. Motivational interviewing and dietary counseling for obesity in primary care: an RCT. Pediatrics 2015; 135(4): 649 - 657. DOI: 10.1542/peds. 2014 - 1880.

63. Broccoli S., Davoli A.M., Bonvicini L. et al. Motivational interviewing to treat overweight children: 24-month follow-up of a randomized controlled trial. Pediatrics 2016; 137(1): e20151979. DOI: 10.1542/peds. 2015 - 197930/wjc.v6.i5.234

64. Croxtall J.D. Valsartan: in children and adolescents with hypertension. Paediatr Drugs 2012; 14(3): 201 - 207. DOI: 10.2165/11208990-000000000-00000

65. , Trivelli A., Picca S., Litwin M., Peco-Antic A., Zurowska A. et al. ESCAPE Trial Group. Strict blood-pressure control and progression of renal failure in children. N Engl J Med 2009; 361(17): 1639 - 1650. DOI: 10.1056/NEJMoa0902066.

66. Wells T., Blumer J., Meyers K.E. Valsartan Pediatric Hypertension Study Group. Effectiveness and safety of valsartan in children aged 6 to 16 years with hypertension. J Clin Hypertens (Greenwich) 2011; 13(5): 357 - 365. DOI: 10.1111/j.1751-7176.2011.00432

67. Webb N.J., Shahinfar S., Wells T.G., Massaad R., Gleim G.W., Santoro E.P. et al. Losartan and enalapril are comparable in hypertension. reducing proteinuria in children. Kidney Int 2012; 82(7): 819 - 826. DOI: 10.1038/ki.2012.210

68. Chu P.Y., Campbell M.J., Miller S.G., Hill K.D. Anti-hypertensive drugs in children and adolescents. World J Cardiol 2014; 6: 234 - 244. DOI: 10.43.

69. Schaefer F., Coppo R., Bagga A., Senguttuvan P., Schlosshauer R., Zhang Y. et al. Efficacy and safety of valsartan in hypertensive children 6 mon to 5 years of age. J Hypertens 2013; 31(5): 993 - 1000. DOI: 10.1097/HJH.0b013e32835f5721

70. Baker-Smith C.M., Benjamin D.K., Califf R.M. Cough in pediatric patients receiving angiotensin-converting enzyme inhibitor therapy or angiotensin receptor blocker therapy in randomized controlled trials. Clin Pharmacol Ther 2010; 87: 668-71. DOI: 10.1038/clpt.2009.231

71. Soffer B, Zhang Z, Miller K, Vogt BA, Shahinfar S. A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of lisinopril for children with hypertension. Am J Hypertens. 2003 Oct; 16(10): 795 - 800. doi: 10.1016/s0895-7061(03) 00900-2. PMID: 14553956

72. ESCAPE Trial Group; , Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, Testa S, Jankauskiene A, Emre S, Caldas-Afonso A, Anarat A, Niaudet P, Mir S, Bakkaloglu A, Enke B, Montini G, Wingen AM, Sallay P, Jeck N, Berg U, Caliskan S, Wygoda S, Hohbach-Hohenfellner K, Dusek J, Urasinski T, Arbeiter K, Neuhaus T, Gellermann J, Drozdz D, Fischbach M, , Wigger M, Peruzzi L, Mehls O, Schaefer F. Strict blood-pressure control and progression of renal failure in children. N Engl J Med. 2009 Oct 22; 361(17): 1639-50. doi: 10.1056/NEJMoa0902066. PMID: 19846849.

73. Sakarcan A, Tenney F, Wilson JT, Stewart JJ, Adcock KG, Wells TG, Vachharajani NN, Hadjilambris OW, Slugg P, Ford NF, Marino MR. The pharmacokinetics of irbesartan in hypertensive children and adolescents. J Clin Pharmacol. 2001 Jul; 41(7): 742-9. doi: 10.1177/00912700122010645. PMID: 11452706.

74. Schaefer F., Litwin M., Zachwieja J., Zurowska A., Turi S., Grosso A. et al. Efficacy and safety of valsartan compared to enalapril in hypertensive children: a 12-week, randomized, double-blind, parallel-group study. J Hypertens 2011; 29(12): 2484 - 2490. DOI: 10.1097/HJH.0b013e32834c625c

75. Trachtman H., Hainer J.W., Sugg J. Efficacy, safety, and pharmacokinetics of candesartan cilexetil in hypertensive children aged 6 to 17 years. J Clin Hypertens (Greenwich) 2008; 10: 743-50. DOI: 10.1111/j.1751-7176.2008.00022

76. Hazan L., Rodriguez O.A., Bhorat A.E., Miyazaki K., Tao B., Heyrman R. et al. Assessment of Efficacy an Olmesartan in Pediatric Hypertension Study Group. A doubleblind, dose-response study of the efficacy and safety of olmesartan medoxomil in children and adolescents with hypertension. Hypertension 2010; 55(6): 1323 - 1330. DOI: 10.1161/HYPERTENSIONAHA.109.147702

77. Simonett G.D., von Vigier R.O., Konrad M., Rizzi M., Fossali E., Bianchetti M.G. Candesartan cilexetil in children with hypertension or proteinuria: preliminary data. Pediatr Nephrol 2006; 21(10): 1480 - 1482.

78. Flynn J.T. Efficacy and safety of prolonged amlodipine treatment in hypertensive children. Pediatr Nephrol 2005; 20(5): 631 - 635.

79. Trachtman H., Frank R., Mahan J.D., Portman R., Restaino I., Matoo T.K. et al. Clinical trial of extended release felodipine in pediatric essential hypertension. Pediatr Nephrol 2003; 18: 548 - 553. DOI: 10.1007/s00467-003-1134-0

80. Sica D.A., Carter B., Cushman W., Hamm L. Thiazide and loop diuretics. J Clin Hypertens (Greenwich) 2011; 13: 639 - 643 DOI: 10.1111/j.1751-7176.2011.00512

81. Karnes J.H., Cooper-DeHoff R.M. Antihypertensive medications: benefits of blood pressure lowering and hazards of metabolic effects. Expert Rev Cardiovasc Ther 2009; 7: 689 - 702. DOI: 10.1586/erc.09.31

82. Li J.S., Flynn J.T., Portman R., Davis I., Ogawa M., Shi H. et al. The efficacy and safety of the novel aldosterone antagonist eplerenone in children with hypertension: a randomized, double-blind, dose-response study. J Pediatr 2010; 157(2): 282 - 287. DOI: 10.1016/j.jpeds.2010.02.042

83. Meyers R.S., Siu A. Pharmacotherapy review of chronic pediatric hypertension. Clin Ther 2011; 33: 1331 - 1356. DOI: 10.1016/j.clinthera.2011.09.003

84. Логачева И.В., Гуничева Е.А. Длительная терапия индапамидом ретард у подростков с артериальной гипертензией 1 степени. Кардиоваскулярная терапия и профилактика. 2011; 10(2): 6 - 12. https://doi.org/10.15829/1728-8800-2011-2-6-12

85. Batisky D.L., Sorof J.M., Sugg J., Llewellyn M., Klibaner M., Hainer J.W. et al. Efficacy and safety of extended release metoprolol succinate in hypertensive children 6 to 16 years of age: a clinical trial experience. J Pediatr 2007; 150(2): 134 - 139. DOI: 10.1016/j.jpeds.2006.09.034

86. Poirier L., The evolving role of receptor blockers in managing hypertension. Can J Cardiol 2012; 28: 334 - 340. DOI: 10.1016/j.cjca.2012.04.001

87. Poirier L., Tobe S.W. Contemporary use of beta-blocker: clinical relevance of subclassification. Can J Cardiol 2014; 30: S9-15. DOI: 10.1016/j.cjca.2013.12.001

88. Gomez AB, Healy M, Donne GD, Bentley S, Makhecha S, Daubeney P, Naqvi N, Till J, Wong L. P10 Initiation of bisoprolol in paediatric patients - experience from a specialist paediatric cardiac centre. Arch Dis Child. 2023; 108(5):5. doi: 10.1136/archdischild-2023-NPPG.9

89. National high blood pressure education program working group on hypertension control in children and adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004; 114 (Suppl 2): 555-76

90. , Calpe J, , Erdine S, Fernandez-Aranda F, Hadjipanayis A, Hoyer PF, Jankauskiene A, , Litwin M, Mancia G, Mazur A, Pall D, Seeman T, Sinha MD, Simonetti G, Stabouli S and Lurbe E (2023) Joint statement for assessing and managing high blood pressure in children and adolescents: Chapter 2. How to manage high blood pressure in children and adolescents. Front. Pediatr. 11: 1140617. doi: 10.3389/fped.2023.1140617

91. Daugherty S.L., Powers J.D., Magid D.J., Tavel H.M., Masoudi F.A., Margolis K.L. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation 2012; 125: 1635 - 1642. DOI: 10.1161/CIRCULATIONAHA.111.068064

92. Narayan H., Webb D.J. New evidence supporting the use of mineralocorticoid receptor blockers in drug-resistant hypertension. Curr Hypertens Rep 2016; 18(5): 34. DOI:10.1007/s11906-016-0643-8

93. Williams B., MacDonald T.M., Morant S., Webb D., Sever P., McInnes G. et al. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment or drug-resistant hypertension (PATHWAY-2): a randomised, doubleblind, crossover trial. Lancet 2015; 386(10008): 2059 - 2068. DOI: 10.1016/S0140-6736(15) 00257-3

94. Hajizadeh N, Assadi F. Resistant hypertension: current status, future challenges. Int J Prev Med. 2014 Mar; 5(Suppl 1):S21-4. PMID: 24791187; PMCID: PMC3990922.

95. Vaidyanathan B. Is there a role for carvedilol in the management of pediatric heart failure? A meta analysis and e-mail survey of expert opinion. Ann Pediatr Cardiol. 2009 Jan; 2(1):74-8. doi: 10.4103/0974-2069.52816. PMID: 20300274; PMCID: PMC2840768.

96. Flynn JT, Mitsnefes M, Pierce C, et al; Chronic Kidney Disease in Children Study Group. Blood pressure in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children study.//Hypertension. 2008; 52(4): 631 - 637.

97. Reynolds B.C., Roem J.L., Sing Ng D.K., Matsuda-Abedini M., Flynn J.T., Furth S.L., Warady B.A., Parekh R.S. Association of Time-Varying Blood Pressure With Chronic Kidney Disease Progression in Children//JAMA Netw Open. 2020 Feb; 3(2): e1921213. doi: 10.1001/jamanetworkopen.2019.21213

98. .Gartenmann A.C., Fossali E., von Vigier R.O., Simonetti G., Schmidtko J., Edefonti A., et al. Better renoprotective effect of angiotensin II antagonist compared to dihydropyridine calcium channel blocker in childhood. Kidney Int 2003; 64(4): 1450 - 1454.

99. do Vale , C., Soares, H., , H. (2019). Neonatal hypertension: focus on diagnosis and therapy. Journal of Pediatric and Neonatal Individualized Medicine (JPNIM), 8(2), e080207. https://doi.org/10.7363/080207

100. Lande MB, Flynn JT. Treatment of hypertension in children and adolescents. Pediatr Nephrol. 2009 Oct; 24(10): 1939-49. doi: 10.1007/s00467-007-0573-4. Epub 2007 Aug 10. PMID: 17690916; PMCID: PMC2756388

101. Baracco R, Mattoo TK Pediatric hypertensive emergencies. Curr Hypertens Rep. 2014; 16(8): 4 56 pmid:24908135

102. Patel NH, Romero SK, Kaelber DC. Evaluation and management of pediatric hypertensive crises: hypertensive urgency and hypertensive emergencies. Open Access Emerg Med. 2012; 4: 85 - 92.

103. Siddiqi N., Shatat I.F. Antihypertensive agents: a long way to safe drug prescribing in children. Pediatr Nephrol 35, 2049 - 2065 (2020). https://doi.org/10.1007/s00467-019-04314-7

104. Hammer GB, Lewandowski A, Drover DR, et al. Safety and efficacy of sodium nitroprusside during prolonged infusion in pediatric patients. Pediatr Crit Care Med. 2015; 16(5): 397 - 403.

105. Tabbutt S., Nicolson S.C., Adamson P.C. et al. The safety, efficacy, and pharmacokinetics of esmolol for blood pressure control immediately after repair of coarctation of the aorta in infants and children: a multicenter, double-blind, randomized trial.//J Thorac Cardiovasc Surg. 2008; 136(2): 321 - 328.

106. Yang W.C., Zhao L.L., Chen C.Y., Wu Y.K.,Chang Y..J, Wu. H.P. First-attack pediatric hypertensive crisis presenting to the pediatric emergency department.//BMC Pediatr. 2012; 12: 200 pmid:23272766

107. Thompson M,Dana T,Bougatsos C, Blazina I, Norris SL. Screening for hypertension in children and adolescents to prevent cardiovascular disease. Pediatrics. 2013; 131(3): 490 - 525.

108. Шайбакова Л.Р., Мелитицкая А.В., Карамова И.М., Яковлева Л.В. Ранние профилактические подходы к проблеме артериальной гипертензии у детей и подростков//Бюллетень ВСНЦ СО РАМН 2007 3 (55), С. 45 - 47.

109. Tran A.H., Urbina E.M. Rationale and Best Practices for Pediatric Cardiology Prevention Programs//Can J Cardiol. 2020 Sep; 36(9): 1541 - 1544.

110. Couch SC, Saelens BE, Levin L, Dart K,Falciglia G, Daniels SR. The efficacy of a clinic-based behavioral nutrition intervention emphasizing a DASH-type diet for adolescents with elevated blood pressure. J Pediatr. 2008; 152(4): 494 - 501.

111. Couch SC, Saelens BE, Levin L, Dart K,Falciglia G, Daniels SR. The efficacy of a clinic-based behavioral nutrition intervention emphasizing a DASH-type diet for adolescents with elevated blood pressure. J Pediatr. 2008; 152(4): 494 - 501.

112. Пономаренко Г.Н., Ковлен Д.В. Физическая и реабилитационная медицина. Клинические рекомендации, основанные на доказательствах./Под ред. А.Н.Разумова. М.: Наука, 2020.

113. Разумов А.Н. Санаторно-курортное лечение: национальное руководство/Под ред. А.Н. Разумова, В.И. Стародубова, Г.Н. Пономаренко. М.: ГЭОТАР-Медиа, 2021. 752 с.